Skip to main content

Patent disclosure and R&D competition in pharmaceuticals

Buy Article:

$55.00 plus tax (Refund Policy)


The prominent role played by patents within the pharmaceutical domain is unquestionable. In this paper, we focus on a relatively neglected implication of patents: the effect of patent-induced information disclosure on the dynamics of R&D and market competition. The study builds upon the combination of two large datasets, linking the information about patents to firm-level data on R&D projects and their outcome. Two case studies in the fields of anti-inflammatory compounds and cancer research complement our analysis. We argue that patent disclosure induces R&D competition and shapes firms' technological trajectories. In fact, we show that under conditions of uncertainty, patent disclosure can contribute to generate knowledge spillovers, promoting multiple parallel research efforts on plausible targets and stimulating private investment and competition.

Keywords: R&D competition; innovation; patent disclosure

Document Type: Research Article


Affiliations: 1: Department of Economics, University of Verona, Verona, Italy 2: IMT Lucca Institute for Advanced Studies, Lucca, Italy,Fondazione CERM, Roma, Italy 3: Faculty of Economics, University of Trento, Trento, Italy 4: Department of Economics, University of Siena, Siena, Italy

Publication date: 2009-01-01

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more